Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review
- PMID: 9820264
- DOI: 10.1001/jama.280.18.1604
Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review
Erratum in
- JAMA 1999 Feb 10;281(6):515
Abstract
Objective: To conduct a systematic review and, where possible, quantitative meta-analysis of the existing evidence regarding the therapeutic efficacy and safety of the saw palmetto plant extract, Serenoa repens, in men with symptomatic benign prostatic hyperplasia (BPH).
Data sources: Studies were identified through the search of MEDLINE (1966-1997), EMBASE, Phytodok, the Cochrane Library, bibliographies of identified trials and review articles, and contact with relevant authors and drug companies.
Study selection: Randomized trials were included if participants had symptomatic BPH, the intervention was a preparation of S repens alone or in combination with other phytotherapeutic agents, a control group received placebo or other pharmacological therapies for BPH, and the treatment duration was at least 30 days.
Data extraction: Two investigators for each article (T.J.W., A.I., G.S., and R.M.) independently extracted key data on design features, subject characteristics, therapy allocation, and outcomes of the studies.
Data synthesis: A total of 18 randomized controlled trials involving 2939 men met inclusion criteria and were analyzed. Many studies did not report results in a method that permitted meta-analysis. Treatment allocation concealment was adequate in 9 studies; 16 were double-blinded. The mean study duration was 9 weeks (range, 4-48 weeks). As compared with men receiving placebo, men treated with S repens had decreased urinary tract symptom scores (weighted mean difference [WMD], -1.41 points [scale range, 0-19] [95% confidence interval (CI), -2.52 to -0.30] [n = 1 study]), nocturia (WMD, -0.76 times per evening [95% CI, -1.22 to -0.32] [n = 10 studies]), and improvement in self-rating of urinary tract symptoms; risk ratio for improvement (1.72 [95% CI, 1.21-2.44] [n = 6 studies]), and peak urine flow (WMD, 1.93 mL/s [95% CI, 0.72-3.14] [n = 8 studies]). Compared with men receiving finasteride, men treated with S repens had similar improvements in urinary tract symptom scores (WMD, 0.37 International Prostate Symptom Score points [scale range, 0-35] [95% CI, -0.45 to 1.19] [n = 2 studies]) and peak urine flow (WMD, -0.74 mL/s [95% CI, -1.66 to 0.18] [n = 2 studies]). Adverse effects due to S repens were mild and infrequent; erectile dysfunction was more frequent with finasteride (4.9%) than with S repens (1.1%; P<.001). Withdrawal rates in men assigned to placebo, S repens, or finasteride were 7%, 9%, and 11%, respectively.
Conclusions: The existing literature on S repens for treatment of BPH is limited in terms of the short duration of studies and variability in study design, use of phytotherapeutic preparations, and reports of outcomes. However, the evidence suggests that S repens improves urologic symptoms and flow measures. Compared with finasteride, S repens produces similar improvement in urinary tract symptoms and urinary flow and was associated with fewer adverse treatment events. Further research is needed using standardized preparations of S repens to determine its long-term effectiveness and ability to prevent BPH complications.
Comment in
- ACP J Club. 1999 May-Jun;130(3):61
-
Saw palmetto for benign prostatic hyperplasia.JAMA. 1999 May 12;281(18):1699. doi: 10.1001/jama.281.18.1699. JAMA. 1999. PMID: 10328068 No abstract available.
Similar articles
-
Phytotherapy for benign prostatic hyperplasia.Public Health Nutr. 2000 Dec;3(4A):459-72. doi: 10.1017/s1368980000000549. Public Health Nutr. 2000. PMID: 11276294
-
Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev. 2002;(3):CD001423. doi: 10.1002/14651858.CD001423. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2 PMID: 12137626 Updated. Review.
-
Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev. 2000;(2):CD001423. doi: 10.1002/14651858.CD001423. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2002;(3):CD001423. doi: 10.1002/14651858.CD001423 PMID: 10796790 Updated. Review.
-
Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3 PMID: 19370565 Free PMC article. Updated. Review.
-
Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Jun 22;6:CD001423. doi: 10.1002/14651858.CD001423.pub4 PMID: 23235581 Free PMC article. Updated. Review.
Cited by
-
Medicinal plants and natural products for treating overactive bladder.Chin Med. 2024 Mar 27;19(1):56. doi: 10.1186/s13020-024-00884-3. Chin Med. 2024. PMID: 38532487 Free PMC article. Review.
-
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.Curr Med Chem. 2024;31(27):4249-4266. doi: 10.2174/0109298673279207231228070533. Curr Med Chem. 2024. PMID: 38243983 Review.
-
Treatment of Benign Prostatic Hyperplasia by Natural Drugs.Molecules. 2021 Nov 25;26(23):7141. doi: 10.3390/molecules26237141. Molecules. 2021. PMID: 34885733 Free PMC article. Review.
-
Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.Skin Appendage Disord. 2020 Nov;6(6):329-337. doi: 10.1159/000509905. Epub 2020 Aug 23. Skin Appendage Disord. 2020. PMID: 33313047 Free PMC article. Review.
-
Self-Assessed Benefits of a Prostate Health Formulation on Nocturia in Healthy Males With Mild Lower Urinary Tract Symptoms: An Open Label Study.Glob Adv Health Med. 2020 Nov 27;9:2164956120973639. doi: 10.1177/2164956120973639. eCollection 2020. Glob Adv Health Med. 2020. PMID: 33294303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous